# Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSE

Study · id `cardio:ct-nct07902739` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07902739](<https://clinicaltrials.gov/study/NCT07902739>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07902739

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 325 participants.

## Technical summary

Registry record NCT07902739. Randomized; no masking; primary purpose treatment. Start 2024-05-17 (actual); primary completion 2026-10-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 325 participants (enrolled count; ClinicalTrials.gov record NCT07902739, source copy `cardio:ctgov-nct07902739-2026-11-18`, retrieved 2026-11-18)
- Started: 2024-05-17 (actual) (ClinicalTrials.gov record NCT07902739, source copy `cardio:ctgov-nct07902739-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2026-10-05 (actual) (ClinicalTrials.gov record NCT07902739, source copy `cardio:ctgov-nct07902739-2026-11-18`, retrieved 2026-11-18)
- Completion: 2026-10-05 (actual) (ClinicalTrials.gov record NCT07902739, source copy `cardio:ctgov-nct07902739-2026-11-18`, retrieved 2026-11-18)
- Countries: Czechia (ClinicalTrials.gov record NCT07902739, source copy `cardio:ctgov-nct07902739-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07902739-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Pulsed Field Ablation of Atrial Fibrillation: CENTAURI Versus FARAPULSE
- Condition: Atrial Fibrillation (AF)
- Condition: Paroxysmal AF
- Condition: Persistent AF
- Intervention (Device): CENTAURI PEF system
- Intervention (Device): FARAPULSE system
- Lead sponsor: St. Anne's University Hospital Brno, Czech Republic
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: St. Anne's University Hospital Brno, Czech Republic (`cardio:org-st-anne-s-university-hospital-brno-czech-republic`)

## Provenance

Content hash: f9926b3639ca9e38fe72a8995e3bf3c13a7595fb7af04a06e85fac88644891e7
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
